Trademark Search in Canada

DESIGN Mark

View On IC.GC.CA

REGISTERED

on 30 Jul 2021

Last Applicant/ Owned by

Biocryst Pharmaceuticals, Inc.

4505 Emperor Blvd.Durham, NC 27703

Serial Number

1908367 filed on 9^th Jul 2018

Registration Number

TMA1105788 registered on 30^th Jul 2021

Registration expiry Date

30^th Jul 2031

Correspondent Address

COLLEEN SPRING ZIMMERMAN

Colleen Spring Zimmerman (FOGLER, RUBINOFF LLP)Scotia Plaza 40 King Street WestSuite 2400 P.O. Box #215TORONTO

ONTARIO

M5H3Y2

DESIGN Mark

Trademark usage description

pharmaceuticals for the treatment of infectious, viral, inflammatory, and immunological diseases and disorders, namely hereditary angioedema, inflamma Read More

Vienna Information

24 . 15 . 21

Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).Pointes de flèches -- Note: Non compris les pointes de flèches en forme d'angles (26.3.23).

25 . 7 . 1

Surfaces or backgrounds covered with repeated geometrical figures or designsSurfaces ou fonds couverts de figures ou de motifs géométriques répétés

25 . 7 . 7

Surfaces or backgrounds covered with dotsSurfaces ou fonds couverts de points

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 16

Quadrilaterals containing other figurative elementsQuadrilatères contenant d'autres éléments figuratifs

26 . 4 . 19

Quadrilaterals with inscriptions projecting beyond one or more of the sides thereofQuadrilatères avec inscriptions débordant un ou plusieurs côtés

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

25 . 5 . 3

Backgrounds divided into two, diagonallyFonds partagés en deux en oblique

Classification Information

Class [005]
Pharmaceuticals for the treatment of infectious, viral, inflammatory, and immunological diseases and disorders, namely hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases, inflammatory skin diseases, respiratory infections, Acquired Immune Deficiency Syndrome (AIDS), Severe Acute Respiratory Syndrome (SARS), Influenza, Coronavirus, Ebola, Zika, and West Nile virus, transplant rejection; pharmaceuticals for the treatment of cancer, namely, cancers of the immune system, namely T-cell and B-cell leukemias and lymphomas; Pharmaceuticals for the treatment of autoimmune diseases, cardiovascular diseases, and immunologic deficiency syndromes.

Classification kind code

Class [042]
Pharmaceutical research and drug development; medical and scientific research, namely, conducting clinical trials for others; development of pharmaceuticals for the treatment of infectious, viral, inflammatory, immunological, autoimmune and cardiovascular diseases and disorders; development of pharmaceuticals for the treatment of cancer, namely, cancers of the immune system such as T-cell and B-cell leukemias and lymphomas; development of pharmaceuticals for the treatment of influenza, AIDS, SARS, Ebola, Zika, and West Nile virus; development of pharmaceuticals for the treatment of hereditary angioedema, inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases.

Classification kind code

Mark Details

Serial Number

1908367

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 21^st Jul 2021	Registration Pending
Submitted for opposition 191 on 21^st Jul 2021	Registration Fee Notice Sent
Submitted for opposition 42 on 28^th Apr 2021	Advertised
Submitted for opposition 26 on 24^th Mar 2021	Approved
Submitted for opposition 27 on 24^th Mar 2021	Approval Notice Sent
Submitted for opposition 22 on 16^th Jun 2020	Search Recorded
Submitted for opposition 20 on 16^th Jun 2020	Examiner's First Report
Submitted for opposition 1 on 10^th Jul 2018	Created
Submitted for opposition 31 on 10^th Jul 2018	Formalized
Submitted for opposition 30 on 9^th Jul 2018	Filed